[1] GATTINONI L,POWELL D J Jr,ROSENBERG S A,et al.Adoptive immunotherapy for cancer:building on success[J].Nat Rev Immunol,2006,6:383-393.
[2] SHOJAEI F,WU X,MALIK A K,et al.Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+myeloid cells[J].Nat Biotechnol,2007,25:911-920.
[3] GABRILOVICH D I,NAGARAJ S.Myeloid-derived suppressor cells as regulators of the immune system[J].Nat Rev Immunol,2009,9:162-174.
[4] RUBÍ B,MAECHLER P.Minireview:new roles for peripheral dopamine on metabolic control and tumor growth:let's seek the balance[J].Endocrinology,2010,151(12):5570-5581.
[5] KIRILLOVA G P,HRUTKAY R J,SHURIN M R,et al.Dopamine receptors in human lymphocytes:radioligand binding and quantitative RT PCR assays[J].J Neurosci Methods,2008,174:272-280.
[6] DIAZ-MONTERO C M,SALEM M L,NISHIMURA M I,et al.Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage,metastatic tumor burden,and doxorubicin-cyclophosphamide chemotherapy[J].Cancer Immunol Immunother,2009,58(1):49-59.
[7] TERABE M,MATSUI S,PARK J M,et al.Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance:abrogation prevents tumor recurrence[J].J Exp Med,2003,198:1741-1752.
[8] SERAFINI P,MECKEL K,KELSO M,et al.Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function[J].J Exp Med,2006,203:2691-2702.
[9] FUJITA M,KOHANBASH G,FELLOWS-MAYLE W,et al.COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells[J].Cancer Res,2011,71(7):2664-2674.
[10] MELANI C,SANGALETTI S,BARAZZETTA F M,et al.Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma[J].Cancer Res,2007,67:11438-11446.
[11] OSTRAND-ROSENBERG S,SINHA P.Myeloid-derived suppressor cells:linking inflammation and cancer[J].J Immunol,2009,182(8):4499-4506.
[12] YOUN J I,COLLAZO M,SHALOVA I N,et al.Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice[J].J Leukoc Biol,2012,91(1):167-181.
[13] LESOKHIN A M,HOHL T M,KITANO S,et al.Monocytic CCR2+myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell Infiltration into the tumor microenvironment[J].Cancer Res,2012,72(4):876-886.
[14] ZHOU Z,FRENCH D L,MA G,et al.Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells[J].Stem Cells,2010,28(3):620-632.
[15] GARCIA M R,LEDGERWOOD L,YANG Y,et al.Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice[J].J Clin Invest,2010,120:2486-2496.
[16] SARKAR C,CHAKROBORTY D,CHOWDHURY U R,et al.Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models[J].Clin Cancer Res,2008,14:2502-2510. |